Related Experiment Video
Updated: Apr 27, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
The use of iodinated contrast media in patients with end-stage renal disease
Sana F Khan1, Kambiz Kalantari
1Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia.
Insights
Iodinated contrast media (ICM) are generally safe for patients with end-stage renal disease (ESRD). Hemodialysis is not routinely recommended after ICM administration, but limiting exposure is advised.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- End-stage renal disease (ESRD) patients face unique challenges with iodinated contrast media (ICM).
- Understanding the safety profiles of different ICM types is crucial for this population.
Purpose of the Study:
- To evaluate the safety and necessity of hemodialysis for ICM removal in ESRD patients.
- To assess the risks associated with various ICM formulations in ESRD.
Main Methods:
- Review of current evidence regarding ICM administration in ESRD.
- Analysis of safety profiles of low-osmolar contrast media (LOCM) and nonionic agents.
- Assessment of potential toxicities and benefits of hemodialysis post-ICM.
Main Results:
- Iodinated contrast media are well-tolerated in ESRD patients.
- Low-osmolar, nonionic ICM exhibit superior safety profiles.
- Current evidence does not support routine hemodialysis for ICM removal or toxicity management in ESRD.
- Limiting ICM exposure and monitoring cardiac function are prudent measures.
Conclusions:
- Hemodialysis is not routinely indicated for ICM removal in ESRD patients.
- Preference for safer ICM formulations (LOCM, nonionic) is recommended.
- Vigilant monitoring is essential for high-risk patients receiving higher ICM doses.
Abstract:
Iodinated contrast agents are well tolerated in ESRD patients. Certain types of ICM, i.e., LOCM and the nonionic agents are associated with better safety profiles. Current available evidence, although not optimal, does not support the need for additional hemodialysis for ICM removal to preserve residual renal function or to treat other potential toxicities of ICM. However, limiting exposure to ICM is a prudent measure in ESRD patients given ICM’s potential toxicity; close monitoring of patients with poor cardiac function is also recommended in subjects receiving higher doses of ICM, especially those receiving HOCM.
More Related Videos
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies VII: Vascular Imaging
Imaging Studies III: Computed Tomography
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies for Cardiovascular System V: CT
Imaging Studies V: Intravenous Urography and Retrograde Pyelography